Nicotine Science & Policy



Follow us on:


Youth using e-cigarettes three times as likely to become daily cigarette smokers

[...] researchers found that in 2014 people age 12 to 24 who used e-cigarettes were three times as likely to become daily cigarette smokers in the future. Among those who reported using a tobacco product, daily use increased with age through age 28. Daily cigarette smoking nearly doubled between 18 to 21 year olds (12 percent) and 25 to 28 year olds (21 percent). "This is the first paper that actually looks at progression to dependent cigarette smoking among young adults. In these data, e-cigarettes are a gateway for those who become daily cigarette smokers," said the study's first author, John P. Pierce, [...]


Lawmakers push to limit vaping products, ban flavors

The availability of vaping products would be sharply curtailed in Connecticut under bills that are being introduced in the General Assembly, including a ban on the sale of all nicotine products in pharmacies, and e-cigarettes within five miles of schools. Lawmakers are also expected to reintroduce legislation from Gov. Lamont that failed in the closure of the General Assembly last March, to ban flavored vaping devices, in attempt to prevent teenagers and young adults from starting what data show can become lifetime habits.


How hopes for Kind Consumer’s alternative to cigarettes went up in smoke

Of all the many business collapses of 2020, perhaps one of the most disappointing was the demise of a smoking-cessation start-up backed by a colourful cast of big City names. Kind Consumer is the London-based developer of the Voke nicotine inhaler device. It had ambitions to upend the multibillion-pound tobacco market by solving one of public health’s most devastating and costly problems: smoking-related disease.


Gov’t policy on public health not for sale — solon

Lawmakers reiterated the call for an investigation on the Food and Drug Administration’s questionable receipt of private funding from international private groups, The Union and Bloomberg Initiative, in exchange for the issuance of pre-defined policies on e-cigarettes or vapor products and heated tobacco products. “Government policies and regulations should not be influenced by any vested foreign interest. It is incumbent for Congress to investigate FDA’s receipt of private funds from known anti-tobacco, anti-ENDS [electronic nicotine delivery systems] and anti-HTP organizations and how these could have shaped the agency’s adopted policies. [...]


Licence to be a must for sale of tobacco products in urban areas

The State government has proposed to make it mandatory for shops in urban areas to obtain licences for selling cigarettes and other tobacco products. The draft bylaws of Karnataka Municipalities (Regulation and inspection of places used for sale of cigarettes and other tobacco products) seek to prohibit sale of cigarettes and other tobacco products without obtaining licenses from the jurisdictional municipal corporations. The provisions of these rules shall apply to all the municipal corporations, including Bruhat Bengaluru Mahanagara Palike (BBMP).


At the root of the opioid crisis is our belief that Big Pharma can cure pain. Can we kick that habit?

Overdoses are a deadly epidemic that we’ll still have to live with after COVID-19 is gone, but without similar promises of vaccination and return to normal – only the hope that we can change our attitudes. Opioid deaths are the epidemic no one wants to think about within the epidemic no one can stop talking about. In the past 3½ years, more than 17,602 Canadians have died of opioid-related overdoses. And between April and June last year, as COVID-19 throttled the country for the first time, overdose deaths jumped a record 58 per cent over the previous quarter. [...]


We aim to bring our readers updates that reflect the wide range of views, debates and discussions currently taking place on nicotine science and policy. Please note that inclusion of an article in our bulletin does not demonstrate endorsement of the contents.
++++++ For more news, visit ++++++

This email was sent to <<Email Address>>
why did I get this?    unsubscribe from this list    update subscription preferences
Nicotine Science and Policy · c/o Knowledge-Action-Change · 8 Northumberland Avenue · London, WC2N 5BY · United Kingdom